{"id":"W2035214881","doi":"10.3111/13696998.2014.979938","title":"Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; Roche (Canada)","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Oncology; Internal medicine; Breast cancer; Neoadjuvant therapy; Inflammatory breast cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001883091,0.0001730587,0.001122948,0.0003259043,0.000032116,0.00001667007,0.0002433273,0.0001428619,0.0002742638],"category_scores_gemma":[0.0003864794,0.0001268817,0.0001690886,0.0002482292,0.0001604669,0.0001105683,0.0000364499,0.0004830119,2.346011e-7],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002189224,"about_ca_system_score_gemma":0.009132836,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.138711,"about_ca_topic_score_gemma":0.5153628,"domain_scores_codex":[0.9978677,0.0001671133,0.0008652643,0.0002286196,0.0005404524,0.0003308205],"domain_scores_gemma":[0.9973892,0.001150084,0.0003995968,0.000171605,0.000356778,0.0005327133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0108724,0.0001927276,0.1912447,0.0002386028,0.001746319,0.0001173548,0.0004528303,0.004465755,0.0001384397,0.00008002468,0.0001083007,0.7903426],"study_design_scores_gemma":[0.01409513,0.002182595,0.9236965,0.001240444,0.0003863018,0.0003141745,0.000598587,0.05315647,0.0007690275,0.00005262251,0.003274414,0.0002337756],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938768,0.0006126849,0.001214225,0.003320165,0.0002118772,0.0005993465,0.0001330043,0.000002284946,0.00002959566],"genre_scores_gemma":[0.9947027,0.004402784,0.0001502049,0.0004505379,0.000199338,0.00005207184,0.000003757521,0.00002735978,0.00001125272],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7901088,"threshold_uncertainty_score":0.9964845,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02427292047140693,"score_gpt":0.3442561130701545,"score_spread":0.3199831925987475,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}